Search

Your search keyword '"P Denton, Christopher"' showing total 254 results

Search Constraints

Start Over You searched for: Author "P Denton, Christopher" Remove constraint Author: "P Denton, Christopher"
254 results on '"P Denton, Christopher"'

Search Results

1. Semi-Supervised Generative Models for Disease Trajectories: A Case Study on Systemic Sclerosis

2. Lysophosphatidic acid receptor 1 inhibition: a potential treatment target for pulmonary fibrosis.

4. Systemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive disease.

5. Effect of nintedanib in patients with systemic sclerosis-associated interstitial lung disease and risk factors for rapid progression.

6. Dyspnoea and cough in patients with systemic sclerosis-associated interstitial lung disease in the SENSCIS trial.

8. Sickle Cell Disease Treatment with Arginine Therapy (STArT): study protocol for a phase 3 randomized controlled trial

9. Nintedanib in Patients With Systemic Sclerosis-Associated Interstitial Lung Disease: Subgroup Analyses by Autoantibody Status and Modified Rodnan Skin Thickness Score.

12. Tocilizumab Prevents Progression of Early Systemic Sclerosis–Associated Interstitial Lung Disease

14. Predictors of progression in systemic sclerosis patients with interstitial lung disease.

15. Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease

16. Autonomically-mediated decrease in microvascular blood flow due to mental stress and pain in sickle cell disease: A target for neuromodulatory interventions.

17. Abatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase II Investigator‐Initiated, Multicenter, Double‐Blind, Randomized, Placebo‐Controlled Trial

21. Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis

22. Minimal Detectable Changes of the Health Assessment Questionnaire–Disability Index, Patient‐Reported Outcomes Measurement Information System‐29 Profile Version 2.0 Domains, and Patient Health Questionnaire‐8 in People With Systemic Sclerosis: A Scleroderma Patient‐Centered Intervention Network Cohort Cross‐Sectional Study

24. The American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic Sclerosis

30. Defining genetic risk factors for scleroderma-associated interstitial lung disease: IRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung disease

31. Twenty-two points to consider for clinical trials in systemic sclerosis, based on EULAR standards

33. Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials.

34. Significant pituitary siderosis is common in transfusion-dependent sickle cell disease

35. Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy.

39. Recurrent episodes of Takotsubo cardiomyopathy in systemic sclerosis

40. Does the Impact of COVID‐19 on Patients With Systemic Sclerosis Change Over Time?

41. Proposed Response Parameters for Twelve‐MonthDrug Trial in Juvenile Systemic Sclerosis: Results of the Hamburg International Consensus Meetings

42. Early treatment with ambrisentan of mildly elevated mean pulmonary arterial pressure associated with systemic sclerosis: a randomized, controlled, double-blind, parallel group study (EDITA study)

45. Consensus on the assessment of systemic sclerosis–associated primary heart involvement: World Scleroderma Foundation/Heart Failure Association guidance on screening, diagnosis, and follow-up assessment

46. Evaluation of Measurement Properties and Differential Item Functioning in the English and French Versions of the University of California, Los Angeles, Loneliness Scale‐6: A Scleroderma Patient‐CenteredIntervention Network (SPIN) Study

49. Assessment of the Systemic Sclerosis–Associated Raynaud's Phenomenon Questionnaire: Item Bank and Short‐FormDevelopment

50. Relapsing polychondritis in systemic sclerosis: A rare vasculitic mimic

Catalog

Books, media, physical & digital resources